Transcript Document

Scottish Patient Safety Programme –
Pharmacist Engagement
Gordon Thomson
Arlene Coulson
Shadi Botros
Pharmacist
Engagement
Medicines management
 Peri-operative
 Critical care
 Paediatrics
 Mental health
 Primary Care
 Sepsis/VTE
 Older People in Acute Care(OPAC)

Scottish Patient Safety Programme
Medicines Management Driver Diagram
Outcomes
Safe &
effective
medicines
management
(Reduce adverse
drug events: r/t
high risk processes
& medicines e.g.
medicines at the
interface and
anticoagulation)
Primary Drivers
Secondary Drivers
Processes, Rules of
Conduct, Structure
Components, Activities
Provide reliable
medicines
management
processes
Coordination of
care
Patient and family
involvement
Use standardised protocols and algorithms
for high risk meds
Routine and reliable patient and laboratory
monitoring
Identify high risk areas using FMEA
Pharmacy consultation service
Identify patients at risk with high-alert
medications
Standardise recovery protocols (e.g.
opiate over-sedation)
Accuracy of medicines at the interface
“One stop” delivery system
Reliable in-hospital handoffs
Communication with primary care
High risk medicines management services
Patient and family education
Self management protocols
JOINT COLLABORATIVE – VENOUS THROMBOEMBOLISM DRIVER DIAGRAM
AIM
Improve delivery of
evidence based care in
prevention of
Venous
Thromboembolism
(VTE)
OUTCOME:
Reliable risk assessment
and appropriate
thromboprophylaxis
administration
95% of adult admissions in
pilot ward by December
2012
95% of all adult hospital
admissions by December
2014
PRIMARY DRIVERS
Reliable Risk Assessment
Reliable Care Delivery
Education
&
Awareness
Culture of Safety
&
Quality Improvement
Patient & Family
Centered care
SECONDARY DRIVERS
Prevent VTE by ensuring a documented VTE risk
assessment is completed within 24 hours of admission
Include all elements of SIGN 122 – prevention and
management of venous thromboembolism
Ensure reliable and documented appropriate
thromboprophylaxis
Ensure timely prescribing and administration of
anticoagulant therapy/mechanical intervention
Provide education and raise awareness of VTE and
improvement methodology.
Ensure competent practitioner completes risk
assessment/prescribes and administers
pharmacological/mechanical thromboprophylaxis
Provide a culture of safety and quality improvement
Ensure executive sponsorship
Provide clinical leadership
Reliable collaboration of multi-disciplinary team
Develop measurement framework to guide
improvement
Ensure Patient and family centred care
Provide patient information on admission
Involve Patient/Family in risk assessment and
treatment process
Promote open communication among team and family
Optimise transitions to home or other facility
Today in Acute Medicine Unit
compliance – 93%
 VTE prophylaxis – 90%
 Medicines reconciliation on
admission – 72% - cause
under investigation
 Antibiotic
* Based on random samples of 5 patients per week
Key messages
Pharmacists can play a key role in patient
safety
 Do not rely on pharmacists alone to deliver
improvements related to medicines
 Match tests of improvement to your
existing resource
 Maximise use of ehealth systems
 How many pharmacists do you have?
